Cardiovascular disease
We carry out world class research focussed on atherothrombosis, pulmonary artery hypertension and neurovascular disease.
Our research includes underpinning science on vascular mechanobiology and inflammation coupled to the development of new treatment strategies for cardiovascular disease.
Researchers in this research theme:
- Professor Tim Chico
- Professor Martina Daly
- Professor Paul Evans
- Dr Maria Fragiadaki
- Professor Sheila Francis
- Professor Allan Lawrie
- Professor Mike Makris
- Dr Jennifer Middleton
- Dr Thomas Nelson
- Dr William Parker
- Professor Eva Qwarnstrom
- Dr Victoria Ridger
- Dr Alex Rothman
- Dr Jovana Serbanovic-Canic
- Professor Rob Storey
- Dr Roger Thompson
Related projects and groups
ECHOES is an international team of doctors, researchers, scientists, and industrial partners aiming to make a giant leap in cardiovascular healthcare – and we need the essential input of patients and the public to shape and develop the funding application to best address the needs of individuals with all forms of heart disease. The ECHOES team has been shortlisted in the British Heart Foundation ‘Big Beat Challenge’, and we are now working to shape our full application. We are looking to recruit up to eight lay members to co-develop this with us. Please read the Role Profile and complete the application form.
We are interested in different types of lung cell and the triggers that activate these cells. Lung cell activation could contribute to respiratory diseases such as asthma.
The objective of this study is to collect detailed longitudinal clinical phenotypic information linked to bio-samples from patients with pulmonary hypertension, cardiovascular disease, and other lung / respiratory diseases including COVID-19 and compare with appropriate control groups including healthy volunteers.
This programme comprises multidisciplinary research across the University of Sheffield and Sheffield Teaching Hospitals NHS Foundation Trust with particular emphasis on patient orientated research. Current project include biomarker discovery, novel therapies and diagnostic imaging.